Pharming Group N.V. (Pharming) is a global biotechnology company that develops and commercializes therapies for rare and ultra-rare diseases with significant unmet need.
The company focuses on immunological and genetic conditions where the company’s…
Analysis
Quality compounder
Pharming Group N.V. is a quality compounder: a well-run business trading at a price that reflects what it is worth. One caution: reported profits have recently run ahead of actual cash, which we track closely.
The price is expensive. You pay 46.8× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone.
The trajectory is moderate and the balance sheet is adequate. The company scores 14/20 on our value-creation score: strong value creator. Analyst sentiment is cautious.
What to watch: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Mar 202616
73
2026
All-time high
73
Jun 2026
All-time low
16
Mar 2026
Average rank
45
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
52
—
—
—
Price/Earnings
34
—
—
—
Price/Book
40
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
18
—
—
—
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.